Dongmyeong Shin, Ph.D.
CEO
Education
- 2018 ~ 2022 Seoul National University, Electrical and Computer Engineering, Ph.D.
Experience
- 2025 ~ Present OmixAI Co., Ltd., CEO
- 2024 ~ 2025 Radisen Co., Ltd., CEO
- 2021 ~ 2024 Radisen Co., Ltd., CTO
Jong-Bae Park, Ph.D.
CTO
Education
- 2002 ~ 2006 Harvard Medical School, Postdoctoral Fellow
Experience
- 2025 ~ Present OmixAI Co., Ltd., CTO
- 2025 ~ Present Kyung Hee University College of Medicine, Full Professor
- 2024 ~ Present Secretary General, Korean Proteome Society; Board Member, Korean Cancer Association
- 2019 ~ 2023 Director, Industry-Academic Cooperation Foundation
- 2018 ~ 2021 Director, Cancer Proteomics Research Center
- 2018 ~ Present Member, Cancer Control Planning Committee
- 2017 ~ 2021 Graduate School Dean, National Cancer Center Graduate School of Cancer Science and Policy
- 2014 ~ Present Professor, National Cancer Center Graduate School of Cancer Science and Policy
- 2006 ~ 2014 Principal Investigator, Rare Cancer Research Branch, National Cancer Center
Jin-Taek Kim
COO
Education
- 1995 ~ 1998 Kookmin University Graduate School of Law (Commercial Law)
Experience
- 2025 ~ Present OmixAI Co., Ltd., COO
- 2019 ~ Present April Bio Co., Ltd., CIO
- 2024 ~ 2025 Radisen Co., Ltd., COO
- 2023 ~ 2024 Saerom Oriental Pharmaceutical, CEO
- 2018 ~ 2019 Castelbajac, Director
- 2011 ~ 2018 Fashion Group Hyungji Co., Ltd., Planning & Coordination Office Director
Ki-Baek Park
CFO
Education
- 2003 ~ 2007 Fudan University Shanghai (Law)
Experience
- 2025 ~ Present OmixAI Co., Ltd., CFO
- 2024 ~ 2025 Radisen Co., Ltd., CFO
- 2020 ~ 2024 ONCOcross Co., Ltd., Business Development Director
- 2018 ~ 2020 ONCOcross Co., Ltd., CFO
- 2019 ~ 2021 SMBina, Planning Team Leader
- 2016 ~ 2018 SM Sino, Technology Investment
- 2014 ~ 2017 Global Bridge Consulting, Director
- 2010 ~ 2013 Hong Kong Glo-Med Group, Director
- 2007 ~ 2010 Hong Kong Shanghai Development Zone Venture Investment